Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblasts

Gene Therapy

Volumn 6, Issue 2, 1999, Pages 157-161

  Dalle, B ^a   Payen, E ^a   Regulier, E ^b   Deglon, N ^b   Rouyer Fessard, P ^a   Beuzard, Y ^a   Aebischer, P ^b  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b Laboratory of Cellular and Molecular Neurotherapies   (Switzerland)

Author keywords

Encapsulation; Erythropoietin; Gene therapy; thalassemia

Indexed keywords

COMPLEMENTARY DNA; DIHYDROFOLATE REDUCTASE; HEMOGLOBIN F; METHOTREXATE; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; CELL STRUCTURE; CONTROLLED STUDY; ENCAPSULATION; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; FEMALE; GENE AMPLIFICATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEMATOCRIT; MOUSE; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETICULOCYTE COUNT; TIME;

EID: 0033028653     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300812     Document Type: Article

References (26)

1. Johnson FM, Lewis SE. Electrophoretically detected germinal mutations induced in the mouse by ethylnitrosourea. Proc Natl Acad Sci USA 1981; 78: 3138-3142.
2. Skow LC et al. A mouse model for β thalassemia. Cell 1983; 34: 1043-1052.
3. 0-thalassemia. Proc Natl Acad Sci USA 1995; 92: 11608-11612.
4. min-globine genes in embryonic stem cells. Proc Natl Acad Sci USA 1995; 92: 9259-9263.
5. Leroy-Viard K, Rouyer-Fessard P, Beuzard Y. Improvement of mouse β thalassemia by recombinant human erythropoietin. Blood 1991; 78: 1596-1602.
6. Sauvage C, Rouyer-Fessard P, Beuzard Y. Improvement of mouse β thalassemia by hydroxyurea. Br J Haematol 1993; 84: 492-496.
7. Rouyer-Fessard P et al. Mouse β thalassemia, a model for the membrane defects of erythrocytes in the human disease. J Biol Chem 1990; 265: 20247-20251.
8. Sorensen S et al. The role of membrane skeletal-associated-α-globin in the pathophysiology of β thalassemia. Blood 1990; 75: 1333-1340.
9. Curcio MJ et al. Compensatory increase in levels of β minor globin in murine β thalassemia is under translational control. J Biol Chem 1986; 261: 16126-16135.
10. Alter BP, Campbell AS, Holland JG, Friend C. Increased mouse minor hemoglobin during erythroid stress: a model for hemoglobin regulation. Exp Hematol 1982; 10: 754-760.
11. v adult mice have fetal and neonatal levels of mouse minor hemoglobin. In: Stamatoyannopoulos G, Nienhuis A (eds). Hemoglobin in Development and Differentiation. Liss: New York, 1981, pp 281-286.
12. Anderson WF et al. Attemps at gene therapy in β-thalassemic mice. Ann NY Acad Sci 1985; 445: 445-451.
13. Rodgers GP et al. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. New Engl J Med 1993; 328: 73-78.
14. Al-Khatti A et al. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. New Engl J Med 1987; 317: 415-420.
15. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89: 4248-4267.
16. Loukopoulos D. New therapies for the haemoglobinopathies. J Int Med 1997; 242: 43-48.
17. Villeval JL et al. Retrovirus-mediated transfer of erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta-thalassemia. Blood 1994; 84: 928-933.
18. Naffakh N et al. Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc Natl Acad Sci USA 1995; 92: 3194-3198.
19. Rinsch C et al. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum Gene Ther 1997; 8: 1881-1889.
20. Naffakh N et al. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther 1996; 7: 11-21.
21. De Franceschi L et al. Combination therapy of erythropoietin, hydroxyurea and clotrimazole in a β thalassemic mouse: a model for human therapy. Blood 1996; 87: 1188-1195.
22. Descamps V et al. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum Gene Ther 1994; 5: 979-985.
23. Svensson EC et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997; 8: 1797-1806.
24. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vector. Nature Med 1996; 2: 545-549.
25. Snyder RO et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997; 8: 1891-1900.
26. 12 myoblasts. Hum Gene Ther 1996; 7: 2135-2146.